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Purpose: Mitral repair confers a survival advantage over medical treatment and replacement for severe mitral regurgitation (MR) in adults, but 
the feasibility and efficacy of repair in the elderly are controversial. The aim of this study was to compare the results of repair and replacement in 
octogenarians.
Methods: We retrospectively analyzed 322 consecutive octogenarian patients (mean age 82.6±2.2 years) who underwent MV repair (n=227, 70%) 
or replacement (n=95, 30%) between 1998-2008 at 2 institutions. Patients undergoing aortic valve replacement were excluded. Study endpoints of 
mortality, morbidity, MR grade on pre-discharge transthoracic echocardiography (TTE), and survival were compared using univariate and multivariate 
analyses.
Results: Thirty-day mortality in patients undergoing isolated elective repair for degenerative disease was 5.4% (4/74). Overall 90-day mortality 
was 18.9% (43/227) for MV repair compared to 31.6% (30/95) for MV replacement (p=0.014). TTE revealed <2+ residual regurgitation in 99% 
of patients (231/232). One-, 3-, and 5-year survivals for elective repair of degenerative disease were significantly better than for replacement. 
Independent predictors of mortality are shown in Table 1.
Conclusions: Mitral repair has superior early and mid-term results in elderly patients. Emergency surgery is the strongest independent predictor of 
mortality in this age group, underlining the importance of close follow-up and timely operative intervention for MV disease. 
Table 1: Independent predictors of 90-day and all mortality in analysis of all patients
90-day Mortality All Mortality
OR 95% CI p-Value OR 95% CI p-Value
Age 1.0 (0.9 - 1.2) 0.403 1.1 (1.0 - 1.1) 0.120
Prior myocardial infarction 2.2 (1.1 - 4.4) 0.022 2.3 (1.5 - 3.5) <0.001
Ejection fraction ≤30% 2.5 (1.1 - 5.8) 0.035 1.8 (1.0 - 3.2) 0.035
Concomitant coronary bypass grafting 2.2 (1.3 - 3.8) 0.004 1.4 (1.0 - 2.1) 0.058
Mitral replacement 2.0 (1.1 - 3.4) 0.014 1.5 (1.0 -2.2) 0.030
Reoperation 1.2 (0.5 - 2.6) 0.723 0.8 (0.4 -1.5) 0.546
Ischemic etiology 0.9 (0.5 - 1.6) 0.650 1.2 (0.8 - 1.8) 0.459
Emergency surgery 5.3 (2.1 - 13.2) <0.001 4.4 (2.6 - 7.4) <0.001
Cardiopulmonary bypass time 1.0 (1.0 - 1.0) 0.227 1.0 (1.0 - 1.0) 0.575
Institution 1.4 (0.8 - 2.5) 0.212 1.1 (0.7 - 1.6) 0.707
